• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿肾结石及其与骨代谢的联系。

Pediatric nephrolithiasis and the link to bone metabolism.

作者信息

Schwaderer Andrew Lawrence, Kusumi Kirsten, Ayoob Rose Mary

机构信息

aNationwide Children's Hospital, The Ohio State University, Department of Pediatrics, Division of Nephrology bThe Research Institute at Nationwide Children's Hospital, Center for Clinical and Translational Medicine cPediatric Nephrology Fellowship, Nationwide Children's Hospital, Ohio, USA.

出版信息

Curr Opin Pediatr. 2014 Apr;26(2):207-14. doi: 10.1097/MOP.0000000000000069.

DOI:10.1097/MOP.0000000000000069
PMID:24535494
Abstract

PURPOSE OF REVIEW

To review the recent publications describing the link between pediatric nephrolithiasis and bone metabolism.

RECENT FINDINGS

Nephrolithiasis incidence is increasing in children and is associated with low bone mineral density (BMD). Affected children are conceptually at risk for fractures and osteoporosis. In addition to abnormal calcium metabolism, inflammation, genetic makeup and dietary habits are being recognized as important factors in the pathophysiology of nephrolithiasis and low bone density. Findings from retrospective reviews suggest that low BMD in children may be improved with citrate or thiazide treatment.

SUMMARY

The healthcare burden from low BMD with subsequent osteoporosis and fracture risk is immense with potential far-reaching effects in patient quality of life and healthcare expense. Bone mass is acquired in the pediatric age range, thus it is important to identify and treat at-risk children. Retrospective reviews in pediatric patients indicate that citrate or thiazide diuretic treatment may improve BMD. We now understand that a relationship exists between nephrolithiasis and low BMD. To improve healthcare for our current patients as well as protect their future health it is important to identify low BMD and initiate strategies to improve BMD in 'at-risk' children.

摘要

综述目的

综述近期描述小儿肾结石与骨代谢之间联系的出版物。

最新发现

儿童肾结石发病率正在上升,且与低骨密度(BMD)相关。患病儿童理论上面临骨折和骨质疏松的风险。除了钙代谢异常外,炎症、基因构成和饮食习惯也被认为是肾结石和低骨密度病理生理学中的重要因素。回顾性研究结果表明,柠檬酸盐或噻嗪类药物治疗可能会改善儿童的低骨密度。

总结

低骨密度以及随之而来的骨质疏松和骨折风险所带来的医疗负担巨大,对患者生活质量和医疗费用可能产生深远影响。骨量在儿童时期获得,因此识别和治疗高危儿童很重要。对儿科患者的回顾性研究表明,柠檬酸盐或噻嗪类利尿剂治疗可能会改善骨密度。我们现在了解到肾结石与低骨密度之间存在关联。为了改善当前患者的医疗状况并保护他们未来的健康,识别低骨密度并启动改善“高危”儿童骨密度的策略很重要。

相似文献

1
Pediatric nephrolithiasis and the link to bone metabolism.小儿肾结石及其与骨代谢的联系。
Curr Opin Pediatr. 2014 Apr;26(2):207-14. doi: 10.1097/MOP.0000000000000069.
2
Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.钙肾结石与骨质脱矿:病理生理学、诊断及药物治疗
Curr Opin Urol. 2014 Nov;24(6):633-8. doi: 10.1097/MOU.0000000000000111.
3
Bone density vs bone quality: what's a clinician to do?骨密度与骨质量:临床医生该怎么做?
Cleve Clin J Med. 2009 Jun;76(6):331-6. doi: 10.3949/ccjm.76a.08041.
4
Nephrolithiasis-associated bone disease: pathogenesis and treatment options.肾结石相关骨病:发病机制与治疗选择。
Kidney Int. 2011 Feb;79(4):393-403. doi: 10.1038/ki.2010.473. Epub 2010 Dec 1.
5
Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.肾结石、骨密度、骨质疏松症与骨折:一项系统评价和比较性荟萃分析
Osteoporos Int. 2016 Nov;27(11):3155-3164. doi: 10.1007/s00198-016-3658-8. Epub 2016 Jun 11.
6
[Image assessment of the treatment effect on osteoporosis: bisphosphonates].骨质疏松症治疗效果的影像学评估:双膦酸盐类药物
Clin Calcium. 2011 Jul;21(7):1041-6.
7
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy study.静脉注射伊班膦酸盐治疗可使男性骨质疏松症患者在两年后恢复正常的骨基质矿化,并减少皮质骨孔隙率:一项配对活检研究。
J Bone Miner Res. 2014 Feb;29(2):440-9. doi: 10.1002/jbmr.2035.
8
Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy.利塞膦酸盐对老年男性麻风病患者腰椎骨密度、骨吸收及椎体骨折发生率的影响。
Lepr Rev. 2006 Jun;77(2):147-53.
9
Corticosteroid exposure not associated with long-term bone mineral density in pediatric liver transplantation.皮质类固醇暴露与儿童肝移植后长期骨密度无关。
J Pediatr Gastroenterol Nutr. 2011 Sep;53(3):326-32. doi: 10.1097/MPG.0b013e3182258656.
10
Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.接受芳香化酶抑制剂治疗早期乳腺癌的绝经后妇女骨折预防的成本效益。
J Clin Oncol. 2012 May 1;30(13):1468-75. doi: 10.1200/JCO.2011.38.7001. Epub 2012 Feb 27.

引用本文的文献

1
Bone Metabolism Defects in Children With Idiopathic Hypercalciuria: An Update.特发性高钙尿症患儿的骨代谢缺陷:最新进展
Cureus. 2025 Apr 24;17(4):e82931. doi: 10.7759/cureus.82931. eCollection 2025 Apr.
2
Beyond the kidney: extra-renal manifestations of monogenic nephrolithiasis and their significance.超越肾脏:单基因肾结石的肾外表现及其意义。
Pediatr Nephrol. 2024 May;39(5):1429-1434. doi: 10.1007/s00467-023-06242-z. Epub 2023 Dec 7.
3
Pediatric Nephrolithiasis.小儿肾结石病
Healthcare (Basel). 2023 Feb 13;11(4):552. doi: 10.3390/healthcare11040552.
4
The Emergence of Kidney Stone Disease During Childhood-Impact on Adults.儿童期肾结石疾病的出现对成年人的影响。
Curr Urol Rep. 2017 Jun;18(6):44. doi: 10.1007/s11934-017-0691-x.